DNA Sequencing Market by Product & Services, Technology, Workflow, Application - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation

List of Tables

The Global DNA Sequencing Market is forecasted to grow significantly, with a projected USD 60.98 billion in 2023 at a CAGR of 19.45% and expected to reach a staggering USD 212.38 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global DNA Sequencing Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global DNA Sequencing Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product & Services, market is studied across Consumables, Instruments, and Services. The Consumables commanded largest market share of 38.65% in 2022, followed by Services.

Based on Technology, market is studied across Next-Generation Sequencing, Sanger Sequencing, and Third Generation DNA Sequencing. The Next-Generation Sequencing is further studied across Targeted Sequencing & Resequencing, Whole Exome Sequencing, and Whole Genome Sequencing. The Third Generation DNA Sequencing is further studied across Nanopore Sequencing and Single-Molecule Real-Time Sequencing. The Next-Generation Sequencing commanded largest market share of 47.12% in 2022, followed by Third Generation DNA Sequencing.

Based on Workflow, market is studied across Data Analysis, Pre-Sequencing, and Sequencing. The Sequencing commanded largest market share of 46.21% in 2022, followed by Data Analysis.

Based on Application, market is studied across Agrigenomics & Forensics, Clinical Investigation, Consumer Genomics, HLA Typing or Immune System Monitoring, Metagenomics, Epidemiology & Drug Development, Oncology, and Reproductive Health. The Metagenomics, Epidemiology & Drug Development commanded largest market share of 24.23% in 2022, followed by Clinical Investigation.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Europe, Middle East & Africa commanded largest market share of 39.23% in 2022, followed by Americas.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global DNA Sequencing Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global DNA Sequencing Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global DNA Sequencing Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global DNA Sequencing Market?

4. What is the competitive strategic window for opportunities in the Global DNA Sequencing Market?

5. What are the technology trends and regulatory frameworks in the Global DNA Sequencing Market?

6. What is the market share of the leading vendors in the Global DNA Sequencing Market?

7. What modes and strategic moves are considered suitable for entering the Global DNA Sequencing Market?

Product Code: MRR-450A0628CD16

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. DNA Sequencing Market, by Product & Services, 2022 vs 2030
4.3. DNA Sequencing Market, by Technology, 2022 vs 2030
4.4. DNA Sequencing Market, by Workflow, 2022 vs 2030
4.5. DNA Sequencing Market, by Application, 2022 vs 2030
4.6. DNA Sequencing Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing cases of genetic disorders across the world
  - 5.1.1.2. Increasing role of NGS in companion diagnostics and personalized medicines
  - 5.1.1.3. Growing usage of DNA sequencing across agrigenomics and forensics
- 5.1.2. Restraints
  - 5.1.2.1. Technical limitations associated with DNA sequencing
- 5.1.3. Opportunities
  - 5.1.3.1. Advancements and developments in DNA sequencing
  - 5.1.3.2. Rising investments in DNA sequencing and single-cell sequencing
- 5.1.4. Challenges
  - 5.1.4.1. Issues associated with the accuracy, reliability, and ethical implications of DNA sequencing
5.2. Market Trends
- 5.2.1. Technological breakthroughs and growing focus on development of efficient diagnosis and treatments in the Americas
- 5.2.2. Increasing burden of rare and chronic diseases expands the usage for DNA sequencing in APAC region
- 5.2.3. Increasing government investments and initiatives for personalized medications, creating the need for DNA sequencing in the EMEA
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter's Five Forces Analysis
- 5.6.1. Threat of New Entrants
- 5.6.2. Threat of Substitutes
- 5.6.3. Bargaining Power of Customers
- 5.6.4. Bargaining Power of Suppliers
- 5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization

6. DNA Sequencing Market, by Product & Services

6.1. Introduction
6.2. Consumables
6.3. Instruments
6.4. Services

7. DNA Sequencing Market, by Technology

7.1. Introduction
7.2. Next-Generation Sequencing
- 7.2.1. Targeted Sequencing & Resequencing
- 7.2.2. Whole Exome Sequencing
- 7.2.3. Whole Genome Sequencing
7.3. Sanger Sequencing
7.4. Third Generation DNA Sequencing
- 7.4.1. Nanopore Sequencing
- 7.4.2. Single-Molecule Real-Time Sequencing

8. DNA Sequencing Market, by Workflow

8.1. Introduction
8.2. Data Analysis
8.3. Pre-Sequencing
8.4. Sequencing

9. DNA Sequencing Market, by Application

9.1. Introduction
9.2. Agrigenomics & Forensics
9.3. Clinical Investigation
9.4. Consumer Genomics
9.5. HLA Typing or Immune System Monitoring
9.6. Metagenomics, Epidemiology & Drug Development
9.7. Oncology
9.8. Reproductive Health

10. Americas DNA Sequencing Market

10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States

11. Asia-Pacific DNA Sequencing Market

11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam

12. Europe, Middle East & Africa DNA Sequencing Market

12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom

13. Competitive Landscape

13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
- 13.3.1. Merger & Acquisition
  - 13.3.1.1. Agilent acquires Avida Biomed, boosting next-generation sequencing for cancer research
- 13.3.2. Agreement, Collaboration, & Partnership
  - 13.3.2.1. Alliance hopes to automate nanopore library preparation
  - 13.3.2.2. Tecan and Oxford Nanopore partnered for long fragment DNA sequencing
  - 13.3.2.3. UPS Healthcare & Oxford Nanopore partner to deliver DNA sequencing tech across APAC
  - 13.3.2.4. UK set to boost genomics expertise through a landmark partnership with Thailand
- 13.3.3. New Product Launch & Enhancement
  - 13.3.3.1. NIH software assembles complete genome sequences on-demand
  - 13.3.3.2. Eurofins Genomics US Launches Express Oxford Nanopore Sequencing Service with Same-Day Results
  - 13.3.3.3. QIAGEN Digital Insights launched ultra-fast NGS analysis able to process a whole genome in 25 minutes for a $1 in cloud computing costs
  - 13.3.3.4. Complete Genomics Launches Full Sequencing Platforms at Biotech Showcase 2023
  - 13.3.3.5. Element Biosciences Unveils New DNA Sequencing Instrument, Chemistry
- 13.3.4. Investment & Funding
  - 13.3.4.1. Illumina Invests in £30M (USD 36.83 million) Venture Fund to Advance Breakthroughs in Human Health
- 13.3.5. Award, Recognition, & Expansion
  - 13.3.5.1. Oxford Nanopore Technologies Teamed up With UPS Healthcare to Accelerate Delivery of New-Generation DNA Sequencing Technology to More Customers in Locations Across Asia Pacific

14. List of Company Mentioned

15. Appendix

15.1. Discussion Guide
15.2. License & Pricing